| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(90)90070-L |
| P698 | PubMed publication ID | 1967721 |
| P2093 | author name string | F B Bianchi | |
| U Volta | |||
| G Ballardini | |||
| M Lenzi | |||
| L Selleri | |||
| M Fusconi | |||
| D Zauli | |||
| F Cassani | |||
| P433 | issue | 8684 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| autoimmune hepatitis | Q786844 | ||
| P304 | page(s) | 258-259 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Type 2 autoimmune hepatitis and hepatitis C virus infection | |
| P478 | volume | 335 |
| Q71818799 | A 28-year-old woman with a combined hepatitic/cholestatic syndrome |
| Q43048642 | Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study |
| Q43041953 | Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies |
| Q27473555 | Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA |
| Q70462060 | Anti-neutrophil antibodies in chronic hepatitis and the effect of alpha-interferon therapy |
| Q42986062 | Antibodies against hepatitis C virus in mixed cryoglobulinemia patients |
| Q42985404 | Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity |
| Q42984286 | Antibody to Hepatitis-C-Virus-Related Proteins in Sera from Alanine-Aminotransferase-Screened Blood Donors and Prospectively Studied Recipients |
| Q42988070 | Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients |
| Q33698251 | Auto-antibodies in hepatitis C. |
| Q54939025 | Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease? |
| Q45085870 | Autoantibodies in hepatitis delta |
| Q62607272 | Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda |
| Q78025889 | Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein |
| Q34024689 | Autoantigen characterization in liver/kidney microsome positive hepatitis |
| Q90093431 | Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination |
| Q59349440 | Autoimmune hepatitis |
| Q71137776 | Autoimmune hepatitis |
| Q45762603 | Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. |
| Q42985293 | Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance |
| Q40590020 | Autoimmune hepatitis. Evolving concepts and treatment strategies |
| Q37080132 | Autoimmune hepatitis: The realities and the uncertainties |
| Q40775169 | Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus |
| Q72898835 | Autoimmunity during alpha-interferon therapy for chronic hepatitis C |
| Q36699786 | Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection |
| Q41662981 | Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C |
| Q72816115 | Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis |
| Q43038818 | Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera |
| Q67555835 | Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis |
| Q34460416 | Chronic active hepatitis |
| Q42986166 | Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis |
| Q43048266 | Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes |
| Q42983646 | Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis |
| Q40720275 | Comparison of the clinical and immunogenetic features between patients with autoimmune hepatitis and patients with type C chronic active hepatitis |
| Q42980909 | Detection of Hepatitis C Virus Antibody in the Absence of Viral RNA in Patients with Autoimmune Hepatitis |
| Q42984201 | Detection of hepatitis C virus antibody in patients with autoimmune hepatitis and other chronic liver diseases |
| Q67486488 | Development of hepatocellular carcinoma in a man with auto‐immune chronic active hepatitis |
| Q40817612 | Diagnostic markers of viral hepatitis B and C. |
| Q36734483 | Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection |
| Q73483411 | Diversity of antinuclear antibody responses in hepatocellular carcinoma |
| Q71818738 | Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes |
| Q70756324 | Epidemiology of hepatitis C virus infection |
| Q36869203 | Establishment of a novel radioligand assay using eukaryotically expressed cytchrome P4502D6 for the measurement of liver kidney microsomal type 1 antibdy in patients with autoimmune hepatitis and hepatitis C virus infection |
| Q43036522 | Etiology of chronic hepatitis in France: predominant role of hepatitis C virus |
| Q43048900 | Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q67992094 | False-positive result of hepatitis C enzyme-linked immunosorbent assay in children with autoimmune hepatitis |
| Q71958731 | Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity |
| Q53359978 | Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. |
| Q42984229 | Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis |
| Q42987944 | Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis |
| Q42980994 | Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis |
| Q43035989 | GB virus C and TT virus infections in Japanese patients with autoimmune hepatitis |
| Q24307534 | HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis |
| Q43479532 | Hepatitis C virus and autoimmunity: Fortuitous association or reality? |
| Q42981769 | Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis |
| Q59830083 | Hepatitis C virus antibodies in acute and chronic liver disease in India |
| Q42980985 | Hepatitis C virus antibody secretion in vitro by peripheral blood lymphocytes |
| Q42982078 | Hepatitis C virus does not cause nonalcoholic steatohepatitis |
| Q27472993 | Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. |
| Q40142234 | Hepatitis C: Recent advances |
| Q42987946 | Hepatitis C: from laboratory to bedside |
| Q36642065 | Hepatitis C: progress and problems |
| Q39478417 | Hepatocellular carcinoma associated with lupoid hepatitis: a review of Japanese reports |
| Q27486176 | Hepatology |
| Q34408786 | Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease |
| Q43038812 | Immunologic and viral markers in the circulation of anti‐HIV negative heroin addicts |
| Q27473546 | Immunological abnormalities and hepatotropic viral infections |
| Q53371048 | Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience. |
| Q43036194 | In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C |
| Q44100312 | Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. |
| Q43163687 | Influence of genes, sex, age and environment on the onset of autoimmune hepatitis |
| Q42978301 | Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. |
| Q42989133 | Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection |
| Q43041939 | Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. |
| Q50101314 | Is there a role for viruses in triggering autoimmune hepatitis? |
| Q34205552 | LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase |
| Q72098236 | LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment |
| Q33220129 | LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry? |
| Q45872748 | Liver/kidney microsome antibody type 1 and hepatitis C virus infection |
| Q42980063 | Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis |
| Q43039482 | Low prevalence of hepatitis C virus infection in patients with auto‐immune hepatitis type 1 |
| Q36379083 | Management of patients with difficult autoimmune hepatitis |
| Q70496892 | Meeting report: International Autoimmune Hepatitis Group |
| Q34308948 | Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences |
| Q27485138 | Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition |
| Q45777834 | Non-organ specific autoantibodies associated with chronic C virus hepatitis. |
| Q42980425 | Non-organ specific autoantibodies in children with chronic hepatitis C. |
| Q42984774 | Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera |
| Q58100731 | Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes |
| Q40915899 | Pathobiology of hepatitis delta virus |
| Q78322634 | Pathogenesis of autoimmune hepatitis |
| Q33720363 | Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. |
| Q40649145 | Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection |
| Q27478411 | Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease |
| Q43749890 | Practical approach to the discovery of a positive HCV serology in a blood donor |
| Q42981509 | Prevalence of antibody to hepatitis C virus in HBsAg‐negative chronic liver disease in Hong Kong using different assays |
| Q43048377 | Prevalence of hepatitis C viral infection in a community in Taiwan. Detection by synthetic peptide-based assay and polymerase chain reaction |
| Q42981438 | Prevalence of hepatitis C virus antibody in a liver transplantation population |
| Q27487881 | Quantitation of hepatitis C virus genome molecules in plasma samples |
| Q36684658 | Review of hepatitis C in Japan |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q42982979 | Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease |
| Q27473006 | Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection |
| Q60364373 | Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C |
| Q70588149 | The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study |
| Q58324429 | The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM |
| Q35350742 | The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis |
| Q33618244 | Treatment of autoimmune hepatitis |
| Q45156141 | Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response |
| Q74133466 | Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1 |
| Q43754284 | Type II autoimmune hepatitis. What is the role of the hepatitis C virus? |
| Q42981816 | Ultrasound-detected abdominal lymphadenopathy in chronic hepatitis C: high frequency and relationship with viremia |
| Q26781765 | Update on Autoimmune Hepatitis |
| Q68008537 | Viral hepatitis |
| Q33624566 | Viral hepatitis |
| Q40567818 | Viral hepatitis in children with renal disease |
Search more.